ClinicalTrials.Veeva

Menu

The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life

M

Menekşe Nazlı AKER

Status

Completed

Conditions

Premenstrual Syndrome

Treatments

Other: Drinking water consumption
Other: Hydrogenated water consumption

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to determine the effect of hydrogenated water on premenstrual symptoms and quality of life in students with premenstrual syndrome.

Research Hypotheses H1 1 Hydrogenated water consumption reduces premenstrual symptoms in students with premenstrual syndrome.

H1 2 Hydrogenated water consumption increases the quality of life in students with premenstrual syndrome.

The research will consist of intervention and control groups. Individuals consuming hydrogen-rich water will be included in the intervention group, whereas individuals consuming normal water will be in the control group. The block randomization method will be used to randomly assign participants who meet the research criteria to the groups. Participants will be provided with hydrogenated water for three cycles.

Enrollment

72 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The length of the menstrual cycle is within normal limits (21-35),
  • Getting a score of 132 or more from the Premenstrual Syndrome Scale,
  • Not receiving medical treatment for PMS,
  • Not having any psychiatric diagnosis.

Exclusion criteria

  • • Irregular menstruation in the last three cycles

    • Having received a psychiatric diagnosis,
    • Having any gynecological disease (abnormal uterine bleeding, myoma, ovarian cyst, etc.)
    • Using contraceptive medication.
    • Individuals' refusal to participate in the study,
    • Participants' non-compliance with the research plan,
    • Participants start receiving PMS treatment during the study period.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

72 participants in 2 patient groups, including a placebo group

Intervention Group
Experimental group
Treatment:
Other: Hydrogenated water consumption
Control Group
Placebo Comparator group
Treatment:
Other: Drinking water consumption

Trial contacts and locations

1

Loading...

Central trial contact

İlknur Gönenç

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems